Which strategy is better for resectable synchronous liver metastasis from colorectal cancer, simultaneous surgery, or staged surgery? Multicenter retrospective analysis

다국어 초록 (Multilingual Abstract)

Purpose: The optimal treatment for synchronous liver metastasis (LM) from colorectal cancer (CRC) depends on various factors. The present study was intended to investigate the oncologic outcome according to the time of resection of metastatic lesions.
Methods: Data from patients who underwent treatment with curative intent for primary CRC and synchronous LM between 2004 and 2009 from 9 university hospitals in Korea were collected retrospectively. One hundred forty-three patients underwent simultaneous resection for primary CRC and synchronous LM (simultaneous surgery group), and 65 patients were treated by 2-stage operation (staged surgery group).
Results: The mean follow-up length was 41.2 ± 24.6 months. In the extent of resection for hepatic metastasis, major hepatectomy was more frequently performed in staged surgery group (33.8% vs. 8.4%, P < 0.001). The rate of severe complications of Clavien-Dindo classification grade III or more was not significantly different between the 2 groups. The 3-year overall survival (OS) rate was 85.0% in staged surgery group and 69.4% in simultaneous surgery group (P = 0.013), and the 3-year recurrence-free survival (RFS) rate was 46.4% in staged surgery group and 30.2% in simultaneous surgery group (P = 0.143). In subgroup analysis based on the location of primary CRC, the benefit of staged surgery for OS and RFS was clearly shown in rectal cancer (P = 0.021 and P = 0.015).
Conclusion: Based on our results, staged surgery with or without neoadjuvant chemotherapy should be considered for resectable synchronous LM from CRC, especially in rectal cancer, as a safe and fairly promising option

참고문헌 (Reference)

1 Adam R, "Tumor progression while on chemotherapy : a contraindication to liver resection for multiple colorectal metastases" 240 : 1052-1061, 2004

2 Yin Z, "Timing of hepatectomy in resectable synchronous colorectal liver metastases(SCRLM) : Simultaneous or delayed" 57 : 2346-2357, 2013

3 Wang Y, "The role of adjuvant chemotherapy for colorectal l iver metastasectomy after pre-operative chemotherapy : is the treatment worthwhile" 8 : 1179-1186, 2017

4 Bolton JS, "Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma" 231 : 743-751, 2000

5 Mayo SC, "Surgical management of patients with synchronous colorectal liver metastasis : a multicenter international analysis" 216 : 707-716, 2013

6 Martin RC 2nd, "Simultaneous versus staged resection for synchronous colorectal cancer liver metastases" 208 : 842-850, 2009

7 Martin R, "Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis" 197 : 233-241, 2003

8 Minagawa M, "Selection criteria for simultaneous resection in patients with synchronous liver metastasis" 141 : 1006-1012, 2006

9 Nakajima K, "Predictive factors for anastomotic leakage after simultaneous resection of synchronous colorectal liver metastasis" 16 : 821-827, 2012

10 Nordlinger B, "Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer(EORTC Intergroup trial 40983) : a randomised controlled trial" 371 : 1007-1016, 2008

11 Mentha G, "Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary" 93 : 872-878, 2006

12 Van Cutsem E, "Metastatic colorectal cancer:ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up" 25 (25): iii1-iii9, 2014

13 Adam R, "Managing synchronous liver metastases from colorectal cancer : a multidisciplinary international consensus" 41 : 729-741, 2015

14 Yoshidome H, "Interval period tumor progression : does delayed hepatectomy detect occult metastases in synchronous colorectal liver metastases" 12 : 1391-1398, 2008

15 신애선, "Increasing Trend of Colorectal Cancer Incidence in Korea, 1999-2009" 대한암학회 44 (44): 219-226, 2012

16 Kopetz S, "Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy" 27 : 3677-3683, 2009

17 Rees M, "Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer : a multifactorial model of 929 patients" 247 : 125-135, 2008

18 Araujo R, "Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer" 20 : 4312-4321, 2013

19 Dindo D, "Classification of surgical complications : a new proposal with evaluation in a cohort of 6336 patients and results of a survey" 240 : 205-213, 2004

20 Lehmann K, "Chemotherapy before liver resection of colorectal metastases : friend or foe" 255 : 237-247, 2012

21 Tomlinson JS, "Actual 10-year survival after resection of colorectal liver metastases defines cure" 25 : 4575-4580, 2007

22 Slesser AA, "A meta-analysis comparing simultaneous versus delayed resections in patients with synchronous colorectal liver metastases" 22 : 36-47, 2013